436 related articles for article (PubMed ID: 30848967)
1. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
[No Abstract] [Full Text] [Related]
2. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
4. Noninterventional, Naturalistic, Retrospective Study to Describe Prescription Patterns of Long-Acting Injectable Antipsychotics and the Impact of Introducing a New Atypical Antipsychotic in the Spanish Province of Tarragona Catchment Area.
Gaviria AM; Franco J; Rico G; Muntané G; Sáez C; Sánchez-Gistau V; de Pablo J; Vilella E
Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28346773
[TBL] [Abstract][Full Text] [Related]
5. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
[TBL] [Abstract][Full Text] [Related]
6. Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder.
Yan T; Greene M; Chang E; Touya M; Broder MS
J Comp Eff Res; 2018 Nov; 7(11):1083-1093. PubMed ID: 30129771
[TBL] [Abstract][Full Text] [Related]
7. Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.
Joo SW; Shon SH; Choi G; Koh M; Cho SW; Lee J
Eur Neuropsychopharmacol; 2019 Sep; 29(9):1051-1060. PubMed ID: 31362852
[TBL] [Abstract][Full Text] [Related]
8. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis.
Sobolevskaia PA; Churilov LP; Fedotkina TV; Stepochkina A; Dolina A; Gvozdetckii AN; Andreev BV; Shoenfeld Y
Psychiatr Danub; 2021; 33(Suppl 4):1106-1112. PubMed ID: 35354176
[TBL] [Abstract][Full Text] [Related]
10. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.
Stroup TS; Bareis NA; Rosenheck RA; Swartz MS; McEvoy JP
J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549494
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients.
Petrić D; Rački V; Gačo N; Kaštelan A; Graovac M
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):197-204. PubMed ID: 30758986
[TBL] [Abstract][Full Text] [Related]
13. Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations-an observational study using blood samples from 1223 patients.
Tveito M; Høiseth G; Haslemo T; Molden E; Smith RL
Eur J Clin Pharmacol; 2021 Aug; 77(8):1201-1208. PubMed ID: 33616704
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
Li H; Rui Q; Ning X; Xu H; Gu N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
[TBL] [Abstract][Full Text] [Related]
15. Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
Patel R; Chesney E; Taylor M; Taylor D; McGuire P
Psychol Med; 2018 Jul; 48(10):1616-1623. PubMed ID: 29039277
[TBL] [Abstract][Full Text] [Related]
16. Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.
Joshi K; Pan X; Wang R; Yang E; Benson C
Curr Med Res Opin; 2016 Nov; 32(11):1873-1881. PubMed ID: 27479694
[TBL] [Abstract][Full Text] [Related]
17. Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
Kim E; Correll CU; Mao L; Starr HL; Alphs L
CNS Spectr; 2016 Dec; 21(6):466-477. PubMed ID: 27629292
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.
Gopal S; Lane R; Nuamah I; Copenhaver M; Singh J; Hough D; Bach M; Savitz A
CNS Drugs; 2017 Sep; 31(9):797-808. PubMed ID: 28660406
[TBL] [Abstract][Full Text] [Related]
19. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
Lai YC; Chiou CC; Chen CH; Huang MC
J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
[No Abstract] [Full Text] [Related]
20. Influence of antipsychotic treatment type and regimen on the functionality of patients with schizophrenia.
Acosta FJ; Chinea E; Hernández JL; Rodríguez F; García-Bello M; Medina G; Nieves W
Nord J Psychiatry; 2014 Apr; 68(3):180-8. PubMed ID: 23672274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]